ストックスクリーナーアプリを入手
3.65
7.67%
0.26
アフターアワーズ：
3.58
-0.07
-1.92%
前日終値:
$3.39
開ける：
$3.43
24時間の取引高:
1.23M
Relative Volume:
1.66
時価総額：
$202.46M
収益：
$163.78M
当期純損益:
$25.88M
株価収益率:
5.6154
EPS:
0.65
ネットキャッシュフロー:
$-28.66M
1週間 パフォーマンス:
+7.35%
1か月 パフォーマンス:
+4.58%
6か月 パフォーマンス:
-16.67%
1年 パフォーマンス:
-44.70%
1日の値動き範囲:
$3.41
$3.77
1週間の範囲:
$2.99
$3.77
52週間の値動き範囲:
$2.645
$8.275
Voyager Therapeutics Inc Stock (VYGR) Company Profile
名前
Voyager Therapeutics Inc
セクター
電話
857-259-5340
住所
75 HAYDEN AVENUE, LEXINGTON, MA
VYGR を他の銘柄と比較する
| 株式 | 価格 | 時価総額 | 収益 | 当期純利益 | 現金流量 | EPS |
|---|---|---|---|---|---|---|
VYGR
Voyager Therapeutics Inc
|
3.65 | 188.04M | 163.78M | 25.88M | -28.66M | 0.65 |
|
VRTX
Vertex Pharmaceuticals Inc
|
395.92 | 99.42B | 11.39B | 3.64B | 3.50B | 13.99 |
|
REGN
Regeneron Pharmaceuticals Inc
|
561.55 | 58.99B | 14.21B | 4.46B | 3.56B | 39.68 |
|
ALNY
Alnylam Pharmaceuticals Inc
|
432.52 | 56.35B | 2.46B | -319.09M | -52.09M | -2.47 |
|
ARGX
Argen X Se Adr
|
646.60 | 39.02B | 3.05B | 1.28B | -614.78M | 19.58 |
|
ONC
Beone Medicines Ltd Adr
|
307.51 | 34.25B | 3.81B | -644.79M | -669.77M | -6.24 |
Voyager Therapeutics Inc Stock (VYGR) Upgrades & Downgrades
| 日付 | アクション | アナリスト | 評価の変更 |
|---|---|---|---|
| 2025-01-10 | 開始されました | Cantor Fitzgerald | Overweight |
| 2024-12-02 | 開始されました | Citigroup | Buy |
| 2024-11-29 | 再開されました | Wedbush | Outperform |
| 2024-10-16 | 開始されました | Leerink Partners | Outperform |
| 2024-03-26 | 開始されました | Guggenheim | Buy |
| 2024-03-19 | 開始されました | H.C. Wainwright | Buy |
| 2024-03-07 | 開始されました | Citigroup | Buy |
| 2024-01-02 | アップグレード | Wells Fargo | Equal Weight → Overweight |
| 2023-05-10 | 開始されました | Truist | Buy |
| 2023-03-10 | 開始されました | Oppenheimer | Outperform |
| 2021-10-07 | アップグレード | Robert W. Baird | Neutral → Outperform |
| 2021-02-26 | ダウングレード | Robert W. Baird | Outperform → Neutral |
| 2021-02-03 | ダウングレード | BTIG Research | Buy → Neutral |
| 2021-02-03 | ダウングレード | Wedbush | Outperform → Neutral |
| 2020-12-24 | ダウングレード | Cantor Fitzgerald | Overweight → Neutral |
| 2020-12-23 | ダウングレード | Raymond James | Outperform → Mkt Perform |
| 2020-11-11 | ダウングレード | Oppenheimer | Outperform → Perform |
| 2020-11-10 | ダウングレード | Raymond James | Strong Buy → Outperform |
| 2020-11-10 | ダウングレード | Wells Fargo | Overweight → Equal Weight |
| 2020-03-19 | 開始されました | The Benchmark Company | Buy |
| 2020-02-06 | 開始されました | Oppenheimer | Outperform |
| 2018-11-15 | アップグレード | Raymond James | Outperform → Strong Buy |
| 2018-09-10 | 再開されました | BTIG Research | Buy |
| 2018-09-10 | ダウングレード | Morgan Stanley | Overweight → Equal-Weight |
| 2018-06-04 | 開始されました | H.C. Wainwright | Buy |
| 2018-03-12 | ダウングレード | Evercore ISI | Outperform → In-line |
| 2018-03-12 | ダウングレード | Wedbush | Outperform → Neutral |
| 2018-02-02 | 開始されました | Morgan Stanley | Overweight |
| 2017-11-28 | 再開されました | Piper Jaffray | Overweight |
| 2017-10-31 | 開始されました | Robert W. Baird | Outperform |
| 2017-10-27 | 開始されました | Canaccord Genuity | Buy |
| 2017-10-23 | 繰り返されました | Stifel | Buy |
| 2017-10-12 | 開始されました | Raymond James | Outperform |
| 2017-08-17 | 開始されました | Evercore ISI | Outperform |
| 2017-07-28 | 再開されました | Stifel | Buy |
すべてを表示
Voyager Therapeutics Inc (VYGR) 最新ニュース
Voyager Therapeutics Extends Cash Runway to 2028 - TipRanks
Wedbush Lowers Voyager Therapeutics (NASDAQ:VYGR) Price Target to $8.00 - MarketBeat
Truist Financial Keeps Their Buy Rating on Voyager Therapeutics (VYGR) - The Globe and Mail
Voyager Therapeutics: Strategic Restructuring and Pipeline Progress Underpin Buy Rating - TipRanks
Voyager Therapeutics Inc. stock trend forecastStock Holding Strategy Long-Term Summary Sheet - Newser
Voyager Therapeutics: Strong Financial Position and Promising Pipeline Drive Buy Rating - TipRanks
Voyager Therapeutics Q2 Earnings: A $33.4 Million SetbackNews and Statistics - IndexBox
Voyager Therapeutics 2025 Q2 Earnings Deepened Losses Amid Extended Cash Runway - AInvest
Voyager Therapeutics Inc earnings missed by $0.04, revenue fell short of estimates - Investing.com South Africa
Voyager Therapeutics (VYGR) Reports Q2 Loss, Lags Revenue Estimates - Yahoo Finance
Voyager Therapeutics: Q2 Earnings Snapshot - News-Times
Voyager Therapeutics Inc reports results for the quarter ended June 30Earnings Summary - TradingView
Voyager Reports Second Quarter 2025 Financial and Operating Results - The Manila Times
Voyager Therapeutics Q2 2025 Financial and Operating Results - TradingView
Voyager Therapeutics Secures Future Through 2028 with $262M Cash, Expands Alzheimer's Pipeline to 4 Programs - Stock Titan
MarineMax (HZO) adds Odilon Almeida Jr.; two directors resign – 8-K | VYGR SEC FilingForm 8-K - Stock Titan
What is the risk reward ratio of investing in Voyager Therapeutics Inc. stockBuild your wealth with consistent stock growth - Jammu Links News
What drives Voyager Therapeutics Inc. stock priceTurbocharged investment results - Jammu Links News
Is Voyager Therapeutics Inc. stock overvalued or undervaluedFree Stock Index Interpretation - Jammu Links News
What analysts say about Voyager Therapeutics Inc. stockFree Real-Time Stock Data - Jammu Links News
What are the technical indicators suggesting about Voyager Therapeutics Inc.Outstanding investment returns - Jammu Links News
How does Voyager Therapeutics Inc. generate profit in a changing economyMarket-crushing stock picks - Jammu Links News
What are the latest earnings results for Voyager Therapeutics Inc.Maximize portfolio value with smart investment plans - Jammu Links News
What are Voyager Therapeutics Inc. company’s key revenue driversMaximize returns with effective portfolio management - Jammu Links News
What catalysts could drive Voyager Therapeutics Inc. stock higher in 2025Achieve consistent profits with disciplined trading - Jammu Links News
What are analysts’ price targets for Voyager Therapeutics Inc. in the next 12 monthsHigh-impact investment strategies - Jammu Links News
Should I hold or sell Voyager Therapeutics Inc. stock in 2025Consistent high-performance stocks - Jammu Links News
What is the dividend policy of Voyager Therapeutics Inc. stockFree Stock Market Knowledge Sharing - Jammu Links News
How many analysts rate Voyager Therapeutics Inc. as a “Buy”Wealth Building Data Feed For Every Investor - jammulinksnews.com
Is Voyager Therapeutics Inc. forming a bottoming baseStock Market Entry Timing Signals Revealed - metal.it
How does Voyager Therapeutics Inc. compare to its industry peersExpert Picks Tracker From AI Tools - Jammu Links News
Voyager Therapeutics Inc. Added to High Probability Setup ListBuy Signal Based on Chart Analysis Confirmed - metal.it
Voyager Therapeutics Inc. Tests 50 Day MA After Sharp DeclineQuick Gain Stock Watch With Indicators Reviewed - metal.it
Pattern Scan Adds Voyager Therapeutics Inc. to WatchlistMarket Entry and Exit Point Tips From Traders - metal.it
Published on: 2025-07-29 08:53:38 - metal.it
Is Voyager Therapeutics Inc. a growth stock or a value stockAI Powered Target Finder For Consistent Profits - jammulinksnews.com
Top Risks to Consider Before Buying Voyager Therapeutics Inc. StockPortfolio Diversification Stock Ideas From Experts - metal.it
What institutional investors are buying Voyager Therapeutics Inc. stockPost Market Review For 2025 - Jammu Links News
Why Voyager Therapeutics Inc. stock attracts strong analyst attentionWatchlist for Smart Swing Trading Updated - metal.it
Is Voyager Therapeutics Inc. a good long term investmentTremendous wealth creation - PrintWeekIndia
Voyager Therapeutics Inc (VYGR) 財務データ
収益
当期純利益
現金流量
EPS
1.67%
大文字化:
|
ボリューム (24 時間):